Related Experiment Video
Updated: Aug 29, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Hepatitis B virus X protein modulates peroxisome proliferator-activated receptor gamma through protein-protein
Youn-Hee Choi1, Ha-il Kim, Je Kyung Seong
1Department of Microbiology and Brain Korea 21 Project of Medical Sciences, Institute for Immunology and Immunological Diseases, Seoul, South Korea.
Abstract:
Ligand activation of peroxisome proliferator-activated receptor gamma (PPARgamma) has been reported to induce growth inhibition and apoptosis in various cancers including hepatocellular carcinoma (HCC). However, the effect of hepatitis B virus X protein (HBx) on PPARgamma activation has not been characterized in hepatitis B virus (HBV)-associated HCC. Herein, we demonstrated that HBx counteracted growth inhibition caused by PPARgamma ligand in HBx-associated HCC cells. We found that HBx bound to DNA binding domain of PPARgamma and HBx/PPARgamma interaction blocked nuclear localization and binding to recognition site of PPARgamma. HBx significantly suppressed a PPARgamma-mediated transactivation. These results suggest that HBx modulates PPARgamma function through protein-protein interaction.
Related Concept Videos
Hepatitis
Regulation of Nuclear Protein Sorting
Inhibitors of Viral Protein Synthesis
TGF - β Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...

